News, NHS trust

Manchester University NHS and NICE partnership to improve implementation and adoption of clinical guidance

A partnership between Manchester University NHS Foundation Trust and the National Institute for Health and Care Excellence has been launched to focus on how clinical guidance is implemented, aiming to make NICE guidance easier to use in everyday care.

In a collaboration expected to last for two years, MFT will work with NICE on practical projects designed to improve clinical guidance implementation, with an aim to help ensure the safe and rapid adoption of innovation. A major part of this will be work to test the integration of NICE recommendations directly within normal workflows in Hive via a “NICE guidance agent”, designed to help clinicians access relevant evidence and advice.

The partnership will also seek to generate real-world evidence to support the assessment of health technologies and the development of associated guidance, with intelligence being shared on promising technologies and emerging challenges to identify where further evaluation may be needed. “MFT’s clinical, research and digital capabilities will help create the real-world evidence NICE needs to assess promising innovations and develop future guidance more quickly and effectively,” NICE states.

MFT CEO Mark Cubbon highlights how the trust’s EPR and established digital and research infrastructure offers a real-world NHS environment to test and evaluate new approaches at scale. “Working with NICE gives us an opportunity to improve how guidance is used within our own services, while generating learning that could support implementation across the wider NHS,” he notes.

Earlier this year, MFT offered an update on the expansion of its Hive EPR across local care organisations, the introduction of a digital and data academy, and the launch of a new secure data analytics platform. Phase 0 of the project was completed in June, covering pre-implementation mobilisation activities such as establishing programme governance, recruiting and onboarding the implementation team, and completing programme planning.

Phase one will now look to implementation, running to planned go-live in October 2027. Subject matter experts have been nominated from across the trust’s services to inform programme and system design, it continues, offering insight into real workflows and frontline realities, and playing a key role to identify risks early and communicate decisions to teams who will be using the system.

The trust also announced a partnership with the Medicines and Healthcare products Regulatory Agency (MHRA) to launch a health innovation sandbox, to test promising innovations in real-world NHS settings. Healthcare solutions to improve patient care and safety will be rapidly evaluated, the MHRA shares, with one of the first tools to test capable of identifying patients at high risk of complications from long-term conditions.

At that time, Mark Cubbon commented: “By creating a clearer route from innovation to safe adoption, we can help people gain faster access to developments that have the potential to improve care, while maintaining the high standards of safety that patients rightly expect,” he added. “The learning we generate here at MFT could help shape how effective innovations are adopted across the wider NHS, and we are excited to share it more widely at the right time.”

Wider trend: Health innovation 

A new technology introduced at Liverpool Heart and Chest Hospital NHS Foundation Trust is enabling specialists to assess lung tissue samples remotely in real time during diagnostic procedures, reportedly helping avoid delays, reduce patient anxiety, and ensure treatment can begin sooner. Remote rapid on-site evaluation (ROSE) technology permits the analysis of samples while a patient is still undergoing an endobronchial ultrasound, the trust explains, highlighting whether enough tissue has been collected for diagnosis. This, it continues, can prevent the inconvenience of further appointments.

Leeds Community Healthcare NHS Trust is inviting local service users to have their say on the use of AI in community services. Anyone who uses LCH community NHS services in Leeds is welcome to take part, the trust says, with recruitment open until January 2027. Participants will complete a telephone or face-to-face questionnaire about AI in healthcare, which will last up to 30 minutes, it continues, as an opportunity to share their views and experiences. Information shared will be kept private, the trust reassures, and names will be removed prior to the use of any answers.

East Suffolk and North Essex NHS Foundation Trust has outlined its “Epic-first” approach to digital, data, and technology transformation, pointing to shifts from digital deployment to optimisation and from digital transformation as a technology programme to an organisational change programme. AI is expected to become a “transformational capability”, ESNEFT says, with initial plans for AVT, clinical decision support, productivity tools, imaging AI, digital pathology, predictive analytics, and operational decision support. “AI will be treated as an enabling capability embedded within clinical, operational and analytical services rather than a standalone technology programme,” it notes. “It will complement professional expertise, reduce administrative burdens and support better informed decision-making.”